Literature DB >> 12109337

Vitamin E and prostate cancer.

Neil E Fleshner1.   

Abstract

Descriptive epidemiologic evidence suggests that environmental exposures, such as diet, have an important causative role in the progression of prostate cancer. Increasing evidence also suggests that vitamin E may be beneficial in preventing prostate cancer or delaying disease progression. Clinical trials have been initiated that should definitively determine the therapeutic benefit, if any, of vitamin E.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109337     DOI: 10.1016/s0094-0143(02)00023-x

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  3 in total

1.  Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Demetrius Albanes; Cathee Till; Eric A Klein; Phyllis J Goodman; Alison M Mondul; Stephanie J Weinstein; Philip R Taylor; Howard L Parnes; J Michael Gaziano; Xiaoling Song; Neil E Fleshner; Powel H Brown; Frank L Meyskens; Ian M Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2014-06-24

Review 2.  Should finasteride be used to prevent prostate cancer?

Authors:  Neil Fleshner; Girish Kulkarni
Journal:  Curr Treat Options Oncol       Date:  2006-09

3.  Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.

Authors:  Stephanie J Weinstein; Ulrike Peters; Jiyoung Ahn; Marlin D Friesen; Elio Riboli; Richard B Hayes; Demetrius Albanes
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.